Author(s): Miftahul Huday
Medical pricing has become a focal point of ethical debate and policy reform across the globe. As healthcare costs continue to rise, governments are intensifying oversight to ensure affordability, transparency, and fairness. This article explores the ethical dilemmas surrounding medical pricing, the role of government regulation, and the tension between profit-driven healthcare models and public welfare. By examining international approaches and policy interventions, it highlights the need for balanced frameworks that protect patients while sustaining innovation and quality care.